Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients

Completed

• Conditions: Elderly; Breast Cancer

• Registration Number: NCT00849758
• Lead Sponsor: Universitaire Ziekenhuizen KU Leuven

Brief Summary

The goal is to study the biology of aging in breast cancer patients, and to study the impact of chemotherapy on aging related blood biomarkers.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-02-20
• Study First Submitted QC: 2009-02-20
• Study First Posted: 2009-02-24
• Study Start: 2009-05
• Primary Completion: 2012-09
• Study Completion: 2014-09
• Status Verified: 2014-12
• Last Update Submitted: 2014-12-08
• Last Update Posted: 2014-12-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 110

Inclusion Criteria

• 70 years or older
• Female
• Early breast cancer
• Candidate for systemic adjuvant therapy

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the primary question is whether Chemotherapy affects biological aging markers, such as telomere length and immune status	2 years

Trial Locations

Locations (2)

Jules Bordet Institute; 🇧🇪 Brussels, Belgium

University Hospitals Leuven; 🇧🇪 Leuven, Belgium